LA JOLLA PHARMACEUTICAL CO Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 14.90 | 97 | 1,445 | 97 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 12.67 | 97 | 1,229 | 1,280,960 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.90 | 61 | 909 | 61 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.67 | 61 | 773 | 74,500 | 74.4 K to 74.5 K (+0.08 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.90 | 24 | 358 | 24 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.67 | 24 | 304 | 568 | 544 to 568 (+4.41 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 14.90 | 94 | 1,401 | 94 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 12.67 | 94 | 1,191 | 6,764 | 6.7 K to 6.8 K (+1.41 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 14.90 | 16 | 238 | 16 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 12.67 | 16 | 203 | 2,131 | 2.1 K to 2.1 K (+0.76 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.30 | 56 | 913 | 56 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.30 | 56 | 913 | 56 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.86 | 56 | 776 | 74,439 | 74.4 K to 74.4 K (+0.08 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.86 | 56 | 776 | 74,439 | 74.4 K to 74.4 K (+0.08 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.30 | 85 | 1,386 | 85 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.30 | 85 | 1,386 | 85 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.86 | 85 | 1,178 | 6,670 | 6.6 K to 6.7 K (+1.29 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.86 | 85 | 1,178 | 6,670 | 6.6 K to 6.7 K (+1.29 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.30 | 15 | 245 | 15 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.30 | 15 | 245 | 15 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.86 | 15 | 208 | 2,115 | 2.1 K to 2.1 K (+0.71 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.86 | 15 | 208 | 2,115 | 2.1 K to 2.1 K (+0.71 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.30 | 89 | 1,451 | 89 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.30 | 89 | 1,451 | 89 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.86 | 89 | 1,233 | 1,280,863 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.86 | 89 | 1,233 | 1,280,863 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.30 | 22 | 359 | 22 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.30 | 22 | 359 | 22 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.86 | 22 | 305 | 544 | 522 to 544 (+4.21 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.86 | 22 | 305 | 544 | 522 to 544 (+4.21 %) |